FDA issued a Warning Letter to Anicare Pharmaceuticals Pvt Ltd. on 2/28/2019 as a result of this inspection.
483 Anicare Pharmaceuticals Aug 2018

483 Anicare Pharmaceuticals Aug 2018

Liming Zhang FDA$119.00 - Available Now

FDA investigators audited the Anicare Pharmaceuticals - Navi Mumbai, India facility and issued inspectional observations (via FDA 483) on 03 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Aug 2018
  • Location: Navi Mumbai, India
  • FEI: 3007450508
Add To Cart
Anicare Pharmaceuticals FDA inspection 483 Aug 2018Add To Cart